Infection Control Citations in Nursing Homes: Compliance and Geographic Variability.

OBJECTIVES

To report the initial compliance with new infection control regulations and geographic disparities in nursing homes (NHs) in the United States.

DESIGN

Retrospective cohort study from November 27, 2017 to November 27, 2019.

SETTING AND PARTICIPANTS

In total, 14,894 NHs in the continental United States comprising 26,201 inspections and 176,841 deficiencies.

METHODS

We measured the cumulative incidence of receiving F880: Infection Prevention and Control deficiencies, geographic variability of F880 citations across the United States, and the scope and severity of the infection control deficiencies.

RESULTS

A total of 6164 NHs (41%) in the continental United States received 1 deficiency for F880, and 2300 NHs (15%) were cited more than once during the 2-year period. Geographic variation was evident for F880 deficiencies, ranging from 20% of NHs in North Carolina to 79% of NHs in West Virginia. Between 0% (Vermont) and 33% (Michigan) of states' NHs were cited multiple times over 2 years. Facilities receiving 2 or more F880 deficiencies were more reliant on Medicaid, for-profit, and served more acute residents. Infection Prevention and Control deficiencies were of similar severity but of greater scope in NHs that were cited multiple times.

CONCLUSIONS AND IMPLICATIONS

As the coronavirus disease 2019 pandemic challenges hospitals with an increased surge of patients from the community, NHs will be asked to accept convalescing patients who were previously infected with the virus. NHs will need to rely on infection control practices to mitigate the effects of the virus in their facilities. Particular attention to NHs that have fared poorly with repeat infection control practices deficiencies might be a good first step to improving care overall and preventing downstream morbidity and mortality among the highest-risk patients.